Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

Mechanisms of persistent NF-kappaB activation by HTLV-I tax.

Harhaj EW, Harhaj NS.

IUBMB Life. 2005 Feb;57(2):83-91. Review.

2.

NF-kappaB in pathogenesis and treatment of adult T-cell leukemia/lymphoma.

Horie R.

Int Rev Immunol. 2007 Sep-Dec;26(5-6):269-81. Review.

PMID:
18027201
3.
4.

Activation of NF-kappaB by HTLV-I and implications for cell transformation.

Sun SC, Yamaoka S.

Oncogene. 2005 Sep 5;24(39):5952-64. Review.

PMID:
16155602
6.

Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites.

Mori N, Ueda A, Ikeda S, Yamasaki Y, Yamada Y, Tomonaga M, Morikawa S, Geleziunas R, Yoshimura T, Yamamoto N.

Cancer Res. 2000 Sep 1;60(17):4939-45.

7.

Human T cell leukemia virus type I Tax activates CD40 gene expression via the NF-kappa B pathway.

Harhaj EW, Harhaj NS, Grant C, Mostoller K, Alefantis T, Sun SC, Wigdahl B.

Virology. 2005 Mar 1;333(1):145-58.

8.
9.

HTLV-1 Tax is a critical lipid raft modulator that hijacks IkappaB kinases to the microdomains for persistent activation of NF-kappaB.

Huang J, Ren T, Guan H, Jiang Y, Cheng H.

J Biol Chem. 2009 Mar 6;284(10):6208-17. doi: 10.1074/jbc.M806390200. Epub 2009 Jan 7.

10.
11.

NF-kappaB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications.

Arima N, Matsushita K, Obata H, Ohtsubo H, Fujiwara H, Arimura K, Kukita T, Suruga Y, Wakamatsu S, Hidaka S, Tei C.

Exp Hematol. 1999 Jul;27(7):1168-75.

PMID:
10390192
12.

Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis.

Ishikawa C, Nakachi S, Senba M, Sugai M, Mori N.

Carcinogenesis. 2011 Jan;32(1):110-9. doi: 10.1093/carcin/bgq222. Epub 2010 Oct 25.

PMID:
20974684
13.
14.

Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells.

Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N, Fujii M.

Blood. 2002 Sep 1;100(5):1828-34.

15.
16.

Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.

Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M, Utsunomiya A, Koga S, Yamada Y, Kamihira S, Okayama A, Kikuchi H, Uozumi K, Yamaguchi K, Higashihara M, Umezawa K, Watanabe T, Horie R.

Blood. 2005 Oct 1;106(7):2462-71. Epub 2005 Jun 14.

17.
18.

Human T cell leukemia virus type 1: the role of Tax in leukemogenesis.

Pise-Masison CA, Jeong SJ, Brady JN.

Arch Immunol Ther Exp (Warsz). 2005 Jul-Aug;53(4):283-96. Review.

PMID:
16088313
19.

Setting the stage for transformation: HTLV-1 Tax inhibition of p53 function.

Pise-Masison CA, Brady JN.

Front Biosci. 2005 Jan 1;10:919-30. Print 2005 Jan 1. Review.

PMID:
15569630
20.

A human T-cell leukemia virus Tax variant incapable of activating NF-kappaB retains its immortalizing potential for primary T-lymphocytes.

Rosin O, Koch C, Schmitt I, Semmes OJ, Jeang KT, Grassmann R.

J Biol Chem. 1998 Mar 20;273(12):6698-703.

Supplemental Content

Support Center